News for 'Dr Reddys'

Why Dr Reddy's had to shut all its units

Why Dr Reddy's had to shut all its units

Rediff.com25 Oct 2020

Security breach came days after the firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V.

Dr Reddy's in SEC list for terrorist state links

Dr Reddy's in SEC list for terrorist state links

Rediff.com30 Jun 2007

The list, posted on a website link launched by the US regulator, includes ABB, HSBC, Nokia, Unilever, Cadbury, Total and Siemens among others.

Dr Reddy's to invest Rs 750 cr in two SEZs

Dr Reddy's to invest Rs 750 cr in two SEZs

Rediff.com20 May 2009

Dr Reddy's Laboratories, the second largest drug maker in the country, would invest about Rs 750 crore.

Dr Reddy's US R&D lab is located in...?

Dr Reddy's US R&D lab is located in...?

Rediff.com6 Apr 2004

Take the rediff business quiz and see how much you know about India's pharmaceutical industry.

Dr Reddy's files with US FDA for generic Zofran

Dr Reddy's files with US FDA for generic Zofran

Rediff.com8 May 2003

Indian drugmaker Dr Reddy's Laboratories said on Thursday it had filed an application with the US Food and Drug Administration to market a generic form of GlaxoSmithKline's anti-nausea drug Zofran.\n\n

Why Dr Reddy's expects FY19 to be stronger and richer

Why Dr Reddy's expects FY19 to be stronger and richer

Rediff.com6 Mar 2018

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015

3-member panel to probe gas leak at Dr Reddy's

3-member panel to probe gas leak at Dr Reddy's

Rediff.com24 Dec 2010

A three-member committee, comprising two officials from the Director of Factories and one pharma expert, will probe the gas leak at a production unit of Dr Reddy's Laboratories (DRL). The Director of Factories will appoint a pharma domain expert soon.

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Rediff.com13 Jun 2016

The combined sales of the branded versions of the products in the US is about $3.5 billion.

AI Effect: 'Nearly 3 Million Jobs Are At Risk In India'

AI Effect: 'Nearly 3 Million Jobs Are At Risk In India'

Rediff.com28 Aug 2026

In the next 36 months nearly 25 to 40 per cent of jobs will be under threat from AI and job losses are inevitable.

Q1 Earnings, West Asia Tensions, Crude Oil to Drive Market Movement This Week

Q1 Earnings, West Asia Tensions, Crude Oil to Drive Market Movement This Week

Rediff.com19 Jul 2026

Indian stock markets this week will be primarily influenced by a series of corporate Q1 earnings, the evolving geopolitical situation in West Asia, and fluctuations in crude oil prices, according to market analysts.

Dr Reddy's Q1 Net up 52.49% at Rs 550 cr

Dr Reddy's Q1 Net up 52.49% at Rs 550 cr

Rediff.com30 Jul 2014

DRL launched four new products in North America during the previous quarter.

Dr Reddy's ups R&D spend 41% in FY04

Dr Reddy's ups R&D spend 41% in FY04

Rediff.com14 Jul 2004

Dr Reddy's to acquire OctoPlus for euro 27.4 million

Dr Reddy's to acquire OctoPlus for euro 27.4 million

Rediff.com22 Oct 2012

Dr Reddy's has offered a price of 0.52 euro in cash for each OctoPlus share.

BCCI CoE still seeking Head of Sports Science amid injury concerns, says V V S Laxman

BCCI CoE still seeking Head of Sports Science amid injury concerns, says V V S Laxman

Rediff.com9 Aug 2026

VVS Laxman, chief of the BCCI Centre of Excellence (CoE), confirmed that the search for a permanent Head of Sports Science and Medicine is ongoing, nearly 18 months after Nitin Patel's departure, despite mounting injury cases among Indian cricketers.

Dr Reddys Lab Q3 net at Rs 93.16 cr

Dr Reddys Lab Q3 net at Rs 93.16 cr

Rediff.com28 Jan 2003

Dr Reddys Laboratories Ltd has posted a net profit of Rs 931.60 million for the quarter ended December 31, 2002 as compared to a net profit of Rs 1615.30 million in the quarter ended December 31,2001.

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Rediff.com17 Nov 2020

Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug-makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.

Vet killed by hippo during treatment at Shivamogga zoo

Vet killed by hippo during treatment at Shivamogga zoo

Rediff.com20 Mar 2026

A veterinarian at the Tavarekoppa Lion and Safari Zoo in Shivamogga, India, died after being attacked by a hippopotamus while providing medical care.

India-centric plans help Dr Reddy's outperform pharma market

India-centric plans help Dr Reddy's outperform pharma market

Rediff.com27 Dec 2019

In November, DRL registered growth of 28 per cent year-on-year (YoY), which was the highest among peers and double that of the industry growth (14.5 per cent).

How Dr Reddy's plans to win the US market

How Dr Reddy's plans to win the US market

Rediff.com17 Mar 2017

The company has launched only 3 new products during 2015 when compared to 14 launches in 2014

Domestic sales a booster dose for pharma revenues

Domestic sales a booster dose for pharma revenues

Rediff.com19 Jan 2026

Buoyant domestic sales are expected to lift revenues for pharma companies by 8-11 per cent in Q3FY26, even as declining generic Revlimid (cancer drug) sales in the US remain a key drag. Most brokerages forecast a modest 2-4 per cent growth in profit after tax (PAT) for the quarter. Hospitals and diagnostics companies, meanwhile, are likely to post much stronger numbers, with revenues seen growing 20-22 per cent year-on-year (Y-o-Y).

'Dr Singh wanted to be treated in India, not abroad'

'Dr Singh wanted to be treated in India, not abroad'

Rediff.com28 Dec 2024

"Dr Manmohan Singh, soon after becoming the prime minister, had himself carried a small table for us to have tea comfortably at his Safdarjung Lane residence instead of asking his house help," Dr Srinath Reddy, who was the chairperson of the PM's medical panel, recalled.

9 Doctors Who Became Leaders

9 Doctors Who Became Leaders

Rediff.com3 Jul 2026

On Doctors' Day this week let's turn the spotlight onto doctors who decided to become leaders.

'Crisis In The Economy Started Last Year'

'Crisis In The Economy Started Last Year'

Rediff.com15 Aug 2026

'It is not because of the war in West Asia, which began on February 28.' 'Petroleum product prices are already going through the roof. They are bound to have a serious inflationary impact.' 'A country's leadership is tested in trying times. It is here that the current leadership is failing.'

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Dr Reddy's Lab-DRDO drug treats heart damage post-Covid, shows US study

Rediff.com8 Nov 2022

A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Rediff.com30 Jul 2020

Apart from favipiravir and remdesivir, its key Covid-19 products, DRL has already launched nutraceutical products and hand sanitisers during the pandemic.

Shivakumar sworn in as Karnataka CM, Siddaramaiah's son joins cabinet

Shivakumar sworn in as Karnataka CM, Siddaramaiah's son joins cabinet

Rediff.com3 Jun 2026

D K Shivakumar has been sworn in as the Chief Minister of Karnataka, with Governor Thaawarchand Gehlot administering the oath of office and secrecy. The ceremony also saw 13 other ministers, including a Deputy CM, taking their oaths, attended by prominent Congress leaders and religious figures.

Semaglutide Ruling Sparks Generic Pharma Boom

Semaglutide Ruling Sparks Generic Pharma Boom

Rediff.com24 Mar 2026

At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.

The 1,164th open letter to Dr Reddy

The 1,164th open letter to Dr Reddy

Rediff.com14 Oct 2003

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Sun Pharma, Dr Reddy's price scrutiny in US reaches next level

Rediff.com21 Oct 2014

On October 2, a legislature committee wrote letters to the 14 companies, initiating an investigation and seeking details about recent price increases in several generic products available in the American market.

Factors that will guide the markets this week

Factors that will guide the markets this week

Rediff.com20 Oct 2025

Equity market investors would track global trends, foreign fund movement and quarterly earnings in a holiday-shortened week ahead, analysts said. Stock exchanges BSE and NSE will conduct a special Muhurat trading session on Tuesday, October 21.

'INDIA Alliance Is Dead'

'INDIA Alliance Is Dead'

Rediff.com28 May 2026

'Congress needs a positive agenda rather than primarily picking up on two business houses.'

Scorching days, restless nights: India battles intense heatwave

Scorching days, restless nights: India battles intense heatwave

Rediff.com23 May 2026

Several parts of India are experiencing a severe heatwave, with temperatures soaring past 44 degrees Celsius. States are issuing alerts and taking measures to protect people and animals from the extreme conditions.

Oppn candidate Reddy urges MPs to vote with conscience in VP polls

Oppn candidate Reddy urges MPs to vote with conscience in VP polls

Rediff.com7 Sep 2025

Opposition candidate B Sudershan Reddy appeals to MPs to vote with conscience in the upcoming vice presidential polls, urging them to prioritize the spirit of India and parliamentary traditions over party loyalty.

We are front-runners in our field: Dr Anji Reddy

We are front-runners in our field: Dr Anji Reddy

Rediff.com21 Jan 2004

I would like to renew our commitment to advancing the frontiers of science in drug discovery, says the chairman of Dr Reddy's Labs.

Nifty ends below 8,600, Dr Reddy's Labs falls 5%; FOMC, BoJ meets eyed

Nifty ends below 8,600, Dr Reddy's Labs falls 5%; FOMC, BoJ meets eyed

Rediff.com26 Jul 2016

The S&P BSE Sensex shed 119 points to close at 27,977 and the Nifty50 dropped 45 points to finish at 8,591.

HUL tops sustainability rankings as India Inc deepens ESG focus

HUL tops sustainability rankings as India Inc deepens ESG focus

Rediff.com19 Feb 2026

Hindustan Unilever (HUL) has topped the Perpetual Capital Hurun India Impact 50 - 2026 list with 53.9 points (on the scale of 0-100), reflecting a strong performance across key sustainable development goals (SDGs), including climate, water, circularity, gender and biodiversity.

India Launches Robotic Surgery Systems for Battlefield Emergencies

India Launches Robotic Surgery Systems for Battlefield Emergencies

Rediff.com9 Apr 2026

The Union Ministry of Health and Family Welfare has launched indigenous robotic technologies, Project Vimana and Project Operion, designed to perform life-saving surgeries on the battlefield, potentially revolutionising emergency care for injured security personnel.

Pietersen eyes England coaching role to refine Test approach

Pietersen eyes England coaching role to refine Test approach

Rediff.com8 Mar 2026

Former England captain Kevin Pietersen has expressed his interest in joining the national team's coaching setup, aiming to refine their approach to Test cricket following their Ashes defeat and scrutiny of the 'Bazball' tactics.